Leapmotor Debuts Global Product C10 and New Technologies at Munich, Launches Global Strategy
5.9.2023 20:27:00 EEST | Business Wire | Press release
On September 4th, Leapmotor made its debut at the IAA MOBILITY 2023 (hereinafter referred to as "Munich Motor Show"), where the "LEAP TOGETHER: Shaping a Shared Technological Future" global press conference was held. The event comprehensively showcased the latest achievement of all-domain in-house development, Leap 3.0 architecture, and the inaugural global model, the C10.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905065907/en/
C10 Model (Photo: Business Wire)
Leapmotor's Founder, Chairman, and CEO, Zhu Jiangming, emphasizes, “Leapmotor's globalization strategy encompasses the internationalization of both products and technology. Over 8 years of all-domain in-house development, Leapmotor has evolved from LEAP1.0 to LEAP3.0. With the arrival of our first global product based on LEAP3.0 architecture, the C10, all of Leapmotor's subsequent products will be designed and developed with a global mindset and adhere to global standards. In the next 2 years, Leapmotor will introduce 5 globally-oriented products in Europe, Asia-Pacific, the Middle East, the Americas, and other regions, offering intelligent mobility experiences to automotive consumers worldwide.”
As a technology-driven intelligent electric vehicle enterprise, Leapmotor remains steadfast in its commitment to all-domain in-house development of core technologies. With an unwavering commitment to shaping a shared future of intelligent mobility, Leapmotor remains devoted to delivering the finest smart mobility experience to all consumers.
Eight Years of All-domain In-house Development, LEAP 3.0 Embodies Cutting-Edge Intelligent Electric Technologies
Leap 3.0, with a central integrated electronic and electrical architecture as its core, encompasses several leading technologies, including CTC 2.0 (Cell-to-Chasis) technology, a latest oil-cooling electric drive, the intelligent cockpit with a Qualcomm Snapdragon 8295 chip, and a leading intelligent driving system. It is also built to global standards, and boasts an 88% interchangeability, imbuing each product with inherent intelligence, comfort, and safety traits.
Leapmotor's [Four-Leaf Clover] central integrated E/E architecture employs a central supercomputing platform, which seamlessly integrates the cockpit domain, pilot domain, power domain, and vehicle body domain, realizing the industry's pioneering convergence of these four domains. Furthermore, it enables vehicle-level seamless over-the-air (OTA) updates for five years. With over 500 reserved interfaces, it ensures Leapmotor to deliver an evolving and personalized driving experience.
Following last year's release of the package-less CTC technology, Leapmotor takes it a step further with CTC 2.0. This advanced technology eliminates modules, incorporates new safety features, and integrates a Battery Management System (BMS). This highly integrated battery-chassis equips the vehicle with attributes of extended range, enhanced safety, superior performance, and accelerated energy replenishment.
The latest oil-cooling electric drive features innovations that span from mid-voltage flat wire technology to high-voltage silicon carbide technology, offering power outputs ranging from 170kW to 250kW to accommodate both rear-wheel drive and all-wheel drive applications. The incorporation of high-voltage silicon carbide technology into the flat wire oil-cooling electric drive achieves a comprehensive efficiency of 92%, all while weighing only 76kg. This results in an ultra-compact and exceptionally powerful solution.
The Leapmotor intelligent cockpit system maximizes the capabilities of a Qualcomm Snapdragon 8295 chip, bestowing the cockpit with robust computing power and a seamless customer experience. The newly developed Leap OS intelligent desktop operating system caters to a multitude of driving scenarios, allowing customizable settings to accommodate diverse usage patterns.
At the intelligent driving level, the vehicle with Leap 3.0 is equipped with 30 high-performance perception hardware components, including LiDAR and an 8 million-pixel HD camera, delivering enhanced precision in perception. It is powered by an NVIDIA DRIVE Orin system-on-a-chip (SoC), which delivers 254 TOPS of computing to enable safe, high-speed and urban NAP intelligent-driving capabilities.
As an all-encompassing solution for intelligent electric vehicle technology, LEAP 3.0 stands as a prominent global leader in the field of intelligent electric vehicle technologies.
Leapmotor Initiates Globalization Strategy through Product Innovation and Technological Advancements
Leapmotor unveils C10 as the first model under LEAP3.0 architecture, marking its inaugural global strategic model. Embracing the signature design language of the Leapmotor family and leveraging the latest innovations of LEAP3.0, C10 embarks on an intelligent evolution to shape the future of mobility.
During the press conference, Mr. Zhu Jiangming stated, "Openness, co-creation, and global collaboration are key to achieving rapid proliferation of intelligent electric vehicles. Looking ahead, Leapmotor is not only an automobile manufacturer but also a comprehensive provider of intelligent electric vehicle solutions."
Globally, Leapmotor offers four different technology cooperation models, ranging from scratch to completion. Additionally, Leapmotor actively engages in strategic partnerships with world-renowned mobility ecosystem partners such as NVIDIA, ZF, Qualcomm, Bosch, and NXP.
The initiation of the global strategy is a critical step for Leapmotor as it leads the way with its competence of all-domain in-house development, driving the company's upward trajectory. It is also a demonstration of the synergy between brand strength, technological prowess, and influence.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230905065907/en/
Contact information
Tammy Hu
hu_huiling@leapmotor.com
Lexi Liu
liu_xinyun@leapmotor.com
+86 15601869865
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 15:00:00 EEST | Press release
Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-making. However, compared to Riskified’s agentic commerce pulse survey in Q4 2025, consumer sentiment has shifted, with growing concerns around fraud, security, and accountability slowing the path to fully autonomous, agent-driven transactions. Key findings from th
Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 15:00:00 EEST | Press release
Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environment. The findings highlight a growing disconnect between ambition and execution. Cross-border transactions are expected to form a significant portion of deal pipelines, with 47% of respondents expecting them to account for between 26% and
Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼ REZZAYO ® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 14:43:00 EEST | Press release
Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing allogeneic HSCT face prolonged periods of immunosuppression and routinely require extended antifungal prophylaxis,1 representing a setting where differentiated dosing, improved side effect profile, and reduced DDI is beneficial, and comparable efficacy is expected. The ReSPECT study met its primary endpoint for US Food and Drug Administration (FDA) and European Medicines
tesa Selects Kinaxis as the Digital Backbone for Global Integrated Business Planning Transformation27.4.2026 14:00:00 EEST | Press release
Kinaxis® (TSX: KXS), a global leader in end‑to‑end supply chain orchestration, today announced that tesa SE, a global manufacturer of adhesive tapes and self-adhesive product solutions, has selected the Kinaxis Maestro™ platform as a core enabler of its global, multi‑year supply chain and integrated business planning (IBP) transformation. Following an extensive evaluation, tesa selected Kinaxis to support its evolution from regionally fragmented planning practices toward a centrally governed, globally orchestrated IBP operatingmodel. Kinaxis will support tesa in improving enterprise-wide transparency, strengthening resilience, and enabling faster, more informed decision making across an increasingly complex and volatile global supply chain network. With 130 years of innovation, tesa is one of the world’s leading manufacturers of adhesive tapes and self-adhesive product solutions. Operating across six global regions and serving both complex industrial and fast-moving consumer markets, t
vVARDIS Announces Investment from Apollo —Achieves Unicorn Status27.4.2026 14:00:00 EEST | Press release
vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415938477/en/ Photo credit: Jos Schmid, Photographer vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulations clinically proven to treat tooth decay. Curodont™ supports en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom